DK3421051T3
(en )
2020-06-22
Methods for glycoconjugation and compositions
DK2925782T3
(en )
2020-04-06
ANTI-CD47 ANTIBODIES AND PROCEDURES FOR USE THEREOF
DK2850202T3
(en )
2020-05-18
METHODS AND GROUPS
DK3550836T3
(en )
2022-01-10
PROCEDURE AND DEVICE DEVICE
DK2929031T5
(en )
2021-08-23
PCSK9-IRNA COMPOSITIONS AND METHODS OF USING IT
DK2884999T3
(en )
2021-01-04
METHOD AND COMPOSITIONS FOR CELLULAR IMMUNTERAPHY
DK3008168T3
(en )
2020-05-04
SC-CELLS AND COMPOSITIONS AND PROCEDURE FOR CREATING THEREOF
DK3468197T3
(en )
2022-05-16
Method for inter-prediction and arrangement thereof
DK2854883T3
(en )
2019-07-15
BIOMATRIX HYDROGES AND PROCEDURES FOR USE THERE
DK3355539T3
(en )
2020-04-27
Methods and devices for channel estimation
DK3196022T3
(en )
2021-05-25
PRINTING SYSTEM AND PROCEDURE
DK2838917T3
(en )
2019-08-26
METHODS AND MEANS FOR CREATING HETERODIMER IG SIMILAR MOLECULES
DK2914291T3
(en )
2022-05-16
ANTI-COMPLEMENT-C1S ANTIBODIES AND USES THEREOF
DK2906684T3
(en )
2020-09-28
T-CELL MODIFIING COMPOUNDS AND USES THEREOF
DK2920167T3
(en )
2020-01-20
Hydrazinyl-indole compounds and conjugates
DK2672967T3
(en )
2019-01-02
RELATIONSHIPS AND METHODS FOR CHINESE MODULATION AND INDICATIONS THEREOF
DK2895607T3
(en )
2021-05-25
DOUBLE-STRING OLIGONUCLEOTIDE MOLECULES FOR DDIT4 AND METHODS FOR USING IT
BR112015007125A2
(en )
2017-07-04
apparatus and method
DK3079719T3
(en )
2019-11-18
ANTI-SIGLEC-8 antibodies and methods for their use
DK2861223T3
(en )
2022-11-07
Compositions and methods for transmucosal absorption
DK3930322T3
(en )
2023-07-31
METHODS AND DEVICES FOR ENCODING
DK2706338T3
(en )
2019-05-20
Detection device and method
DK3379339T3
(en )
2020-04-20
Process cartridge and imaging device
DK2908661T3
(en )
2020-02-03
MICROALGULE GRANULATES AND PROCEDURE FOR PREPARING THEREOF
DK3381461T3
(en )
2021-05-17
PEPTIDES AND PROCEDURES FOR USING IT